Petrobras (NYSE:PBR) was downgraded by equities researchers at Tudor Pickering from a “buy” rating to a “hold” rating in a note issued to shareholders on Tuesday.
Advertisement
PBR has been the topic of a number of other research reports.
Many analysts are providing their Estimated Earnings analysis for Petroleo Brasileiro S.A. – Petrobras and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $0.17/share. Overweight rating was given by “0” and Underweight rating was given by “2”. HSBC upgraded Petroleo Brasileiro SA – Petrobras from a hold rating to a buy rating in a research report on Thursday, September 8th.
12/15/2015 – Credit Agricole began new coverage on Petroleo Brasileiro S.A. – Petrobras giving the company a “underperform” rating. Vetr’s price objective would indicate a potential upside of 12.18% from the stock’s current price. However brokerage recommendations suggests an ABR of 3.64 based on calls of 8 experts, where 1 brokers polls the stock a Strong Buy, 0 suggest the stock a Buy, 2 suggest Hold, 1 are rating the stock as Sell while 3 as Strong Sell.
Wall Street analysts taken into consideration for the Zacks Research consensus have set a mean target price of $11.25 on company shares.
On 9/14/2016, Petroleo Brasileiro S.A (NYSE:PBR-A) finished the previous buying and selling session with the price of $7.79. The stock’s market capitalization is 58.37B.
IMMUNE PHARMACEUTICALS INC. (IMNP) received consensus recommendation of “Buy” from Analysts polled at Thomson Reuters. Petroleo Brasileiro SA Petrobras (ADR) (NYSE:PBR) shares were trading -12.89% below from the 52-week high price mark of $10.24 and 229.15% above from the 52-week price bottom of $2.71. “5” rated “Sell” for the company. Emerald Acquisition Ltd. bought a new stake in shares of Petroleo Brasileiro SA – Petrobras during the second quarter worth approximately $57,271,000.
03/24/2016 – Petroleo Brasileiro S.A. – Petrobras was downgraded to “sell” by analysts at Deutsche Bank.
A number of large investors have recently added to or reduced their stakes in PBR. (IMNP): announced that it has entered into a stock purchase agreement with an existing stockholder for the sale of 4,000,000 shares of the Company’s common stock at a fixed price of $0.50 per share, for gross proceeds of $2,000,000.
09/01/2015 – Petroleo Brasileiro S.A. – Petrobras had its “neutral” rating reiterated by analysts at UBS. 3 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0.
Investors and analysts will be closely watching when the company next reports earnings numbers.
Advertisement
Petroleo Brasileiro SA Petrobras is a Brazil-based integrated energy company. The Company operates in the Exploration and Production (E&P); Refining, Transportation and Marketing (RTM); Gas and Power; Biofuels; Distribution, and worldwide segments. The Company is engaged in prospecting, drilling, refining, processing, trading and transporting crude oil from producing onshore and offshore oil fields and from shale or other rocks, as well as oil products, natural gas and other liquid hydrocarbons.
